COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab

被引：0
|
作者：
Anne H. Cross
Silvia Delgado
Mario Habek
Maria Davydovskaya
Brian J. Ward
Bruce A. C. Cree
Natalia Totolyan
Ratnakar Pingili
Linda Mancione
Xixi Hu
Roseanne Sullivan
Wendy Su
Ronald Zielman
Ayan Das Gupta
Xavier Montalban
Kevin Winthrop
机构：
[1] Washington University,Department of Neurology
[2] University of Miami Miller School of Medicine,Infectious Diseases Division
[3] University Hospital Center Zagreb,UCSF Weill Institute for Neurosciences, Department of Neurology
[4] University of Zagreb,Department of Neurology
[5] School of Medicine,Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat)
[6] Moscow State Public Healthcare InsCity Clinical Hospital 24,undefined
[7] Research Institute of the McGill University Health Centre,undefined
[8] University of California San Francisco,undefined
[9] First Saint Petersburg State Medical University,undefined
[10] Novartis Pharmaceuticals Corporation,undefined
[11] Novartis Pharma B.V.,undefined
[12] Novartis Healthcare Private Limited,undefined
[13] Hospital Universitari Vall d’Hebron,undefined
[14] School of Public Health at Oregon Health and Science University,undefined
来源：
Neurology and Therapy | 2022年 / 11卷
关键词：
ALITHIOS; Anti-CD20 therapy; B-cell therapy; COVID-19; Ofatumumab; Post-marketing; Relapsing multiple sclerosis; SARS-CoV-2; Vaccination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：741 / 758
页数：17
相关论文
共 50 条
  • [1] COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab
    Cross, Anne H.
    Delgado, Silvia
    Habek, Mario
    Davydovskaya, Maria
    Ward, Brian J.
    Cree, Bruce A. C.
    Totolyan, Natalia
    Pingili, Ratnakar
    Mancione, Linda
    Hu, Xixi
    Sullivan, Roseanne
    Su, Wendy
    Zielman, Ronald
    Das Gupta, Ayan
    Montalban, Xavier
    Winthrop, Kevin
    NEUROLOGY AND THERAPY, 2022, 11 (02) : 741 - 758
  • [2] Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumab
    Bar-Or, Amit
    Aburashed, Rany
    Chinea, Angel R.
    Hendin, Barry A.
    Lucassen, Elisabeth
    Meng, Xiangyi
    Stankiewicz, James
    Tullman, Mark J.
    Cross, Anne H.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
  • [3] Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab
    Adamec, Ivan
    Rogic, Dunja
    Penz, Monika-Gabriele
    Braun, Carola
    Habek, Mario
    JOURNAL OF NEUROIMMUNOLOGY, 2022, 362
  • [4] COVID-19 Vaccination Response in Patients with Multiple Sclerosis Treated with Ofatumumab in the United States: A Medical Record Review
    Dave, Rahul H.
    Crayton, Heidi
    Miravalle, Augusto
    Tai, Ming-Hui
    Wyse, Kerri
    Houghton, Katherine
    Hitchens, Abby
    Berkovich, Regina
    NEUROLOGY AND THERAPY, 2024, 13 (06) : 1737 - 1745
  • [5] Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis
    Allen-Philbey, K.
    Stennett, A.
    Begum, T.
    Johnson, AC.
    Dobson, R.
    Giovannoni, G.
    Gnanapavan, S.
    Marta, M.
    Smets, I.
    Turner, B. P.
    Baker, D.
    Mathews, J.
    Schmierer, K.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [6] COVID-19 Vaccination and Disease Course in People with Multiple Sclerosis in Greece
    Bakirtzis, Christos
    Konstantinidou, Natalia
    De Lorenzo, Sotiria Stavropoulou
    Moysiadis, Theodoros
    Boziki, Marina-Kleopatra
    Grigoriadou, Eleni
    Kesidou, Evangelia
    Theotokis, Paschalis
    Thireos, Eleftherios
    Mitrou, Panagiota
    Grigoriadis, Nikolaos
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (17)
  • [7] Did it hurt? COVID-19 vaccination experience in people with multiple sclerosis
    Allen-Philbey, K.
    Stennett, A.
    Begum, T.
    Johnson, A. C.
    MacDougall, A.
    Green, S.
    Dobson, R.
    Giovannoni, G.
    Gnanapavan, S.
    Marta, M.
    Smets, I.
    Turner, B. P.
    Baker, D.
    Mathews, J.
    Schmierer, K.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 65
  • [8] COVID-19 vaccination willingness among people with multiple sclerosis
    Xiang, Xinran M.
    Hollen, Chris
    Yang, Qian
    Brumbach, Barbara H.
    Spain, Rebecca, I
    Wooliscroft, Lindsey
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (02)
  • [9] COVID-19 vaccination uptake in people with multiple sclerosis compared to the general population
    Mayer, Dijana
    Barun, Barbara
    Lazibat, Karla
    Lasic, Slava
    Adamec, Ivan
    Gabelic, Tereza
    Skoric, Magdalena Krbot
    Habek, Mario
    ACTA NEUROLOGICA BELGICA, 2023, 123 (06) : 2269 - 2275
  • [10] Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination
    Zaloum, Safiya A.
    Wood, Callum H.
    Tank, Pooja
    Upcott, Matthew
    Vickaryous, Nicola
    Anderson, Valerie
    Baker, David
    Chance, Randy
    Evangelou, Nikos
    George, Katila
    Giovannoni, Gavin
    Harding, Katharine E.
    Hibbert, Aimee
    Ingram, Gillian
    Jolles, Stephen
    Kang, Angray S.
    Loveless, Samantha
    Moat, Stuart J.
    Richards, Aidan
    Robertson, Neil P.
    Rios, Francesca
    Schmierer, Klaus
    Willis, Mark
    Dobson, Ruth
    Tallantyre, Emma C.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (08) : 979 - 989
12345